Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.
about
Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.Is chronic hepatitis C virus infection a risk factor for breast cancer?Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control studyComparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis.Ethical considerations regarding classroom use of personal genomic information.SI RLTD: Risk Scores and Decision Making: The Anatomy of a Decision to Reduce Breast Cancer Risk.How do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study.A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.Impact of presymptomatic genetic testing on young adults: a systematic review.Genetics: breast cancer as an exemplarNursing advocacy in a postgenomic age.Cancer risk management decision making for BRCA+ women.Heightened perception of breast cancer risk in young women at risk of familial breast cancer.The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.Families dealing with the uncertainty of genetic disorders: the case of Neurofibromatosis Type 1.Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.Families' experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk population.Family Communication, Risk Perception and Cancer Knowledge of Young Adults from BRCA1/2 Families: a Systematic Review.Living With Genetic Vulnerability: a Life Course Perspective.Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations.A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers.HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer.Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.Quality of life and autonomy in emerging adults with early-onset neuromuscular disorders.'Cancer doesn't have an age': genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24.Subtle Psychosocial Sequelae of Genetic Test ResultsMind over matter. The impact of subjective social status on health outcomes and health behaviors
P2860
Q27316521-FFC1BD5A-91D2-4613-B2CD-5BCE7B0FFFA7Q33650424-BC6A9A2F-7791-4E84-AE5C-5793C31AEF36Q34041411-EAC482AF-5CE8-4E52-88E0-2B962D9F0763Q34083182-83987036-D119-4314-9286-843B3AC23E38Q34410245-7446A706-29BE-4E4F-9234-8CA776D2CB28Q34782009-531BD1E1-C8A8-4F7D-80C6-5AB492F955E2Q35072487-B7654E28-7FF8-4FD7-A078-522310E82FC5Q35225559-FBD2033B-0814-4BBE-88E6-13B3A86E56B5Q36487269-C607CD3E-2EE0-4617-860A-2CC9357A92D6Q37058022-937EAF11-D773-4423-8E06-84C4024A5939Q37357662-F38F3166-7BA4-4ED6-8A28-DD6C72FC6EAAQ37398136-176A9B5B-6BB3-40D9-B306-B4B438B1C456Q38564191-F6E98C03-419E-4D62-BBB1-14E014672395Q38684207-A7C0803A-D3E8-4B44-8FA9-BD86811C8E4DQ38842957-D511B3E9-B16E-49BD-A5A3-24BB91C494A6Q38909768-92327A9C-D1CC-4A3A-BEA9-8985A62F7EABQ39196584-08375221-2AF2-42FA-ACD3-0198F8D58420Q39241186-70D94155-C5F3-42C8-B9AD-9ED5C61FC98CQ39292307-1A3D23B5-04EB-4536-B524-975BE7BB802CQ39408271-06157F1C-F84E-424C-8C3F-F43D38CB77A3Q40590078-BDC8B69D-2EE7-4955-878E-299DEF7C26BCQ41695403-9B18AFB5-0F69-44C1-AF5D-601DD2549C72Q42671498-08B3850A-654C-43DC-9270-C1666E472B00Q44400604-56FC84CF-50F7-4E8A-A251-90351D45FD79Q47247097-B4FA8180-E2E1-4D35-8495-F7FEAF268CBDQ48027758-900E8E6D-1A6E-4387-868E-58450D920485Q48476886-6246944B-CBA0-48B1-A30B-F84FA5B36494Q51788159-9AC2E051-9EA1-4B9D-A023-6DC6D1CA1A0EQ57778792-59050A3F-6E4C-4D5E-AB7D-80598C87F603Q58763747-B29212F3-7EA7-4FB6-B30A-C52AFB5C8D7D
P2860
Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Life trajectories, genetic tes ...... ary breast and ovarian cancer.
@ast
Life trajectories, genetic tes ...... ary breast and ovarian cancer.
@en
type
label
Life trajectories, genetic tes ...... ary breast and ovarian cancer.
@ast
Life trajectories, genetic tes ...... ary breast and ovarian cancer.
@en
prefLabel
Life trajectories, genetic tes ...... ary breast and ovarian cancer.
@ast
Life trajectories, genetic tes ...... ary breast and ovarian cancer.
@en
P2860
P1476
Life trajectories, genetic tes ...... ary breast and ovarian cancer.
@en
P2093
Kathleen Calzone
Rebekah Hamilton
P2860
P304
P356
10.1007/S10897-008-9200-1
P577
2008-11-01T00:00:00Z